💊 UAE’s Julphar goes big; Navidea goes to India; Mystery hepatitis goes to Israel

Apr 20, 2022

∙ Paid

Many congratulations, sunshine and bunnies, to Kabler #8! And happy mid-week to everyone else except pets in China.

In today’s Kable: India looks to build a supply chain tracker; J&J dims outlook on Covid; Big Doctor is watching; Rology gets money; THREAD stitches together one more buy; Epygen to begin trials for a low-cost Covid vaccine.

Keep reading with a 7-day free trial

Subscribe to The Kable to keep reading this post and get 7 days of free access to the full post archives.